The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Targeting AXL for the treatment of pancreatic cancer.

Kathleen  Ludwig

No Relationships to Disclose

Rolf A.  Brekken

Stock and Other Ownership Interests  - Peregrine Pharmaceuticals; Tuevol Therapeutics

Honoraria - Peregrine Pharmaceuticals

Consulting or Advisory Role - Peregrine Pharmaceuticals

Research Funding - BerGenBio; Lilly/ImClone; Peregrine Pharmaceuticals

Patents, Royalties, Other Intellectual Property - Peregrine Pharmaceuticals; Tuevol Therapeutics

Travel, Accommodations, Expenses - Peregrine Pharmaceuticals